Bifidobacterium longum subsp. infantis CCFM1269 promotes intestinal barrier and release of IFN-β through TLR4-TRIF dependent way in growing mice

Bifidobacterium longum subsp. infantis CCFM1269 promotes intestinal barrier and release of IFN-β through TLR4-TRIF dependent way in growing mice

Bifidobacterium longum subsp. infantis is a commensal bacterium that predominates in the infant gut, playing a critical role in both preventing foreign infections and facilitating immune development. This study aimed to explore the effects of B. longum subsp. infantis supplementation on interferon-b...

Full description

Saved in:

Bibliographic Details
Main Authors:	Mengfan Ding, Bo Yang, Bowen Li, Haiqin Chen, Renqiang Yu, Ross R. Paul, Catherine Stanton, Shilong Jiang, Jianxin Zhao, Wei Chen
Format:	Article
Language:	English
Published:	Tsinghua University Press 2025-01-01
Series:	Food Science and Human Wellness
Subjects:	bifidobacterium longum subsp. infantis intestinal barrier interferon-beta (ifn-β) secretion age dependence
Online Access:	https://www.sciopen.com/article/10.26599/FSHW.2024.9250025
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Bifidobacterium longum subsp. infantis CCFM1426 enhances the anti-colitic effect of vitamin A via retinoic acid restoration and gut microbiota modulation in ulcerative colitis mice
by: Xihua Yu, et al.
Published: (2025-07-01)

Clinical effects of Bifidobacterium Longum Subsp. Infantis YLGB-1496 on children with respiratory symptoms
by: Pin Li, et al.
Published: (2025-02-01)

Indole Derivatives Biosynthesis in Bifidobacterium longum subsp. infantis and the Tryptophan Substrate Availability
by: Shi‐Min Zhang, et al.
Published: (2025-06-01)

Selection and in vitro Probiotic Properties of Bifidobacterium longum subsp. longum with Anti-diabetic Activity from the Intestinal Tract of Chinese Tajik Children
by: LI Si, AN Meiling, LI Longlong, ZHANG Ruirui, SUN Hailong, NI Yongqing
Published: (2025-05-01)

Scientific Opinion on the substantiation of a health claim related to a combination of bifidobacteria (Bifidobacterium bifidum, Bifidobacterium breve, Bifidobacterium infantis, Bifidobacterium longum) and decreasing potentially pathogenic intestinal microorganisms pursuant to Article 14 of Regulation (EC) No 1924/2006
by: EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)
Published: (2009-12-01)

Untargeted metabolomic analysis uncovers metabolic variability of four Bifidobacterial strains for probiotic development
by: Kailong Liu, et al.
Published: (2025-01-01)

Multi-omics analyses the effect of Bifidobacterium longum subsp. longum BL21 supplementation on overweight and obese subjects: a randomized, double-blind, placebo-controlled study
by: Xiaoya Wang, et al.
Published: (2025-07-01)

Bifidobacterium longum subsp. longum dipro-O: a potential therapeutic agent for ameliorating metabolic disorders in high-fat diet-induced obesity mouse model
by: Ning Xu, et al.
Published: (2025-06-01)

Effectiveness of Bifidobacterium longum 35624 in the treatment of patients with irritable bowel syndrome: a systematic review
by: D. Andreev, et al.
Published: (2024-06-01)

Effects of <i>Bifidobacterium longum longum</i> 35624® on the Symptoms and Quality of Life in Patients with Irritable Bowel Syndrome: Results of the Multicenter Observational Program SAGA
by: V. T. Ivashkin, et al.
Published: (2024-12-01)

A novel source of phytochemical and bioactive peptide from fermented mushroom trimming waste extract by Bifidobacterium longum
by: Napassorn Peasura, et al.
Published: (2025-06-01)

Effect of inulin on the growth and survival of Bifidobacterium longum BB536 in fermented goat’s and cow’s milk
by: Marina Šimunek, et al.
Published: (2009-09-01)

Association of alterations in transcriptomics and intestinal immune responses with Bifidobacterium longum BAA2573 in improving dextran sulfate sodium-induced colitis
by: Wujuan Hao, et al.
Published: (2025-08-01)

Synergistic amelioration of obesity in high‐fat diet–fed mice by Bifidobacterium longum and green banana powder through targeting multiple pathways
by: Yi‐Yao Lu, et al.
Published: (2025-01-01)

Uptake of fucosylated type I human milk oligosaccharide blocks by Bifidobacterium longum subsp. infantis
by: Morten Ejby Hansen, et al.
Published: (2025-08-01)

Bifidobacterium longum JBLC-141 alleviates hypobaric hypoxia-induced intestinal barrier damage by attenuating inflammatory responses and oxidative stress
by: Xiang-Yang Li, et al.
Published: (2024-12-01)

Fexofenadine HCl enhances growth, biofilm, and lactic acid production of Limosilactobacillus reuteri and Bifidobacterium longum: implications for allergy treatment
by: Zainab Kamel Hammouda, et al.
Published: (2025-07-01)

Priority effects, nutrition and milk glycan-metabolic potential drive Bifidobacterium longum subspecies dynamics in the infant gut microbiome
by: Nicholas Pucci, et al.
Published: (2025-01-01)

Inhibitory effect of goat and cow milk fermented with Bifidobacterium longum bb-46 on growth of uropathogenic Candida albicans
by: Vedran Slačanac, et al.
Published: (2004-10-01)

Stress Resistance of Biofilm-type Bifidobacterium longum subsp. longum and Its Effect on Intestinal Microbiota
by: Shuang YAN, et al.
Published: (2025-08-01)

Bifidobacterium longum mediated tryptophan metabolism to improve atopic dermatitis via the gut-skin axis
by: Zhifeng Fang, et al.
Published: (2022-12-01)

Amelioration of inflammatory bowel disease by Bifidobacterium animalis subsp. lactis XLTG11 in combination with mesalazine
by: Weiwei Ma, et al.
Published: (2024-12-01)

Comparative in silico analyses between Lactiplantibacillus plantarum and Bifidobacterium longum concerning probiotic properties, anti-lipidemic, and anti-diabetic in vitro activities
by: Asmaa Negm El-Dein, et al.
Published: (2025-06-01)

Scientific Opinion on the substantiation of health claims related to a combination of Lactobacillus gasseri PA 16/8, Bifidobacterium bifidum M 20/5 and Bifidobacterium longum SP 07/3 and maintenance of upper respiratory tract defence against pathogens (ID 931, further assessment) pursuant to Article 13(1) of Regulation (EC) No 1924/2006
by: EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)
Published: (2012-06-01)

Role of Bifidobacterium animalis subsp. lactis BB-12 in mice with acute pancreatitis
by: Bingbing Du, et al.
Published: (2025-04-01)

Targeted probiotic therapy in irritable bowel syndrome: a clinical evaluation on Clostridium butyricum CBM588 and Bifidobacterium longum W11
by: Alexander Bertuccioli, et al.
Published: (2025-05-01)

Bifidobacterium animalis subsp. lactis modulates early‐life immune response and gut metabolism
by: Haoming Du, et al.
Published: (2025-06-01)

The influence of lactulose on growth and survival of probiotic bacteria Lactobacillus acidophilus La-5 and Bifidobacterium animalis subsp. lactis BB-12 in reconstituted sweet whey
by: Bojan Matijević, et al.
Published: (2009-03-01)

Effect of Bifidobacterium animalis subsp. lactis Bi66 on Alleviating Constipation and Regulating Gut Microbiota
by: Zhixian CHEN, et al.
Published: (2025-04-01)

Bifidobacterium breve CCFM1078 regulates bone development in growing BALB/c mice via gut microbiota and metabolites to balance bone formation and resorption
by: Bowen Li, et al.
Published: (2025-01-01)

Assessment of the efficacy of a feed additive consisting of Bifidobacterium longum CNCM I‐5642 (PP102I) for dogs (Nestlé Enterprises S.A.)
by: EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP), et al.
Published: (2025-03-01)

Influence of probiotic strain Bifidobacterium animalis subsp. lactis lafti® b94, inulin and transglutaminase on the properties of set- style yoghurt
by: Maja Benković, et al.
Published: (2008-05-01)

Synergistic defecation effects of Bifidobacterium animalis subsp. lactis BL-99 and fructooligosaccharide by modulating gut microbiota
by: Qi Zhang, et al.
Published: (2025-01-01)

Interactions between the human milk oligosaccharide 2′-fucosyllactose and Bifidobacterium longum subspecies infantis in influencing systemic immune development and function in piglets
by: Victoria C. Daniels, et al.
Published: (2024-10-01)

Development of Alginate Composite Microparticles for Encapsulation of <i>Bifidobacterium animalis</i> subsp. <i>lactis</i>
by: Marko Vinceković, et al.
Published: (2024-11-01)

Antibiotic Resistance in <i>Bifidobacterium animalis</i> subsp. <i>lactis</i> and <i>Bifidobacterium longum</i>: Definition of Sensitivity/Resistance Profiles at the Species Level
by: Mario Terlizzi, et al.
Published: (2025-07-01)

Predictive modeling of Bifidobacterium animalis subsp. lactis Bb-12 growth in cow’s, goat’s and soy milk
by: Vedran Slačanac, et al.
Published: (2013-11-01)

A double blinded randomized placebo trial of Bifidobacterium animalis subsp. lactis BLa80 on sleep quality and gut microbiota in healthy adults
by: Yinhua Liu, et al.
Published: (2025-04-01)

Bifidobacterium animalis subsp. lactis A6 alleviates perennial allergic rhinitis in adults by inhibiting serum total IgE and IL‐13: A randomized, double‐blind, placebo‐controlled trial
by: Langrun Wang, et al.
Published: (2025-06-01)

Bacteria-Assisted Celastrol Liposomes for Effective Chemotherapy Against Lung Cancer in Mice Model
by: Wang X, et al.
Published: (2025-04-01)